(Q85074145)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21988290%20AND%20SRC:MED&resulttype=core&format=json

14 February 2020

title

The importance of the comparator in economic evaluations: working on the efficiency frontier (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21988290%20AND%20SRC:MED&resulttype=core&format=json

14 February 2020

author name string

Mattias Neyt

series ordinal

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21988290%20AND%20SRC:MED&resulttype=core&format=json

14 February 2020

Hans Van Brabandt

series ordinal

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21988290%20AND%20SRC:MED&resulttype=core&format=json

14 February 2020

publication date

1 November 2011

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21988290%20AND%20SRC:MED&resulttype=core&format=json

14 February 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21988290%20AND%20SRC:MED&resulttype=core&format=json

14 February 2020

volume

29

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21988290%20AND%20SRC:MED&resulttype=core&format=json

14 February 2020

issue

11

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21988290%20AND%20SRC:MED&resulttype=core&format=json

14 February 2020

page(s)

913-916

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21988290%20AND%20SRC:MED&resulttype=core&format=json

2-year follow-up of trastuzumab after adjuvant chemotherapy in HER2-positive breast cancer: a randomised controlled trial.

14 February 2020

cites work

1 reference

12 December 2020

Trastuzumab for the treatment of primary breast cancer in HER2-positive women: a single technology appraisal

1 reference

12 December 2020

Trastuzumab in early stage breast cancer: a cost-effectiveness analysis for Belgium

1 reference

12 December 2020

Cardiac-resynchronization therapy with or without an implantable defibrillator in advanced chronic heart failure

1 reference

12 December 2020

Economic evaluation of long-term management strategies for erosive oesophagitis

1 reference

12 December 2020

Questions about adjuvant trastuzumab still remain

1 reference

12 December 2020

Cost effectiveness of implantable cardioverter-defibrillators for primary prevention in a Belgian context

1 reference

12 December 2020

Combined resynchronisation and implantable defibrillator therapy in left ventricular dysfunction: Bayesian network meta-analysis of randomised controlled trials

1 reference

12 December 2020

Adjuvant docetaxel or vinorelbine with or without trastuzumab for breast cancer

1 reference

12 December 2020